In the ever-evolving realm of healthcare, the Immunohistochemistry market emerges as a crucial player, offering insights into disease diagnosis and therapeutic decisions. A recent analysis unveils the market's trajectory, revealing its estimated worth of $3.2 billion in 2023, with projections soaring to $4.7 billion by 2028, marking a